Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Or Refractory Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03671460
What this trial is testing

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Tianjin Mycure Medical Technology Co., Ltd 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03278782
What this trial is testing

Study of Pembrolizumab (MK-3475) in Combination With Romidepsin

Who this might be right for
Recurrent Anaplastic Large Cell LymphomaRecurrent Angioimmunoblastic T-Cell LymphomaRecurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma+8 more
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)WithdrawnNCT05152459
What this trial is testing

Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Recurrent Follicular LymphomaRefractory Follicular Lymphoma
City of Hope Medical Center
Early research (Phase 1)Study completedNCT01561833
What this trial is testing

A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients

Who this might be right for
T Cell Lymphoma
Yale University 12
Testing effectiveness (Phase 2)Study completedNCT00513955
What this trial is testing

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Lymphoma
University Hospital Plymouth NHS Trust 50
Testing effectiveness (Phase 2)Looking for participantsNCT07284433
What this trial is testing

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Lymphoma Diffuse Large B-cellLeukemia and LymphomaLeukemia Relapse+1 more
AvenCell Therapeutics, Inc. 178
Early research (Phase 1)Study completedNCT04049825
What this trial is testing

Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL

Who this might be right for
Relapsed or Refractory Diffuse Large B-cell Lymphoma
Otsuka Pharmaceutical Co., Ltd. 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04680052
What this trial is testing

Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

Who this might be right for
Follicular LymphomaMarginal Zone Lymphoma
Incyte Corporation 654
Testing effectiveness (Phase 2)Looking for participantsNCT06160843
What this trial is testing

Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma

Who this might be right for
Relapsed Peripheral T-Cell LymphomaRefractory Peripheral T-Cell Lymphoma
National Cancer Centre, Singapore 24
Testing effectiveness (Phase 2)Ended earlyNCT04358458
What this trial is testing

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Who this might be right for
Diffuse Large B-cell LymphomaFollicular LymphomaMarginal Zone Lymphoma+5 more
Genmab 46
Early research (Phase 1)UnknownNCT05127135
What this trial is testing

Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies

Who this might be right for
T-Acute Lymphoblastic LeukemiaT-cell Non-Hodgkin LymphomaT-cell Acute Lymphoblastic Lymphoma
Fundamenta Therapeutics, Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00521014
What this trial is testing

GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 14
Early research (Phase 1)Ended earlyNCT00087009
What this trial is testing

Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT03309878
What this trial is testing

Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell LymphomaRecurrent Transformed B-Cell Non-Hodgkin Lymphoma+3 more
National Cancer Institute (NCI) 8
Early research (Phase 1)Looking for participantsNCT06820268
What this trial is testing

XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
B-cell LymphomaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04697940
What this trial is testing

Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL

Who this might be right for
Relapsed and Refractory B-cell Non-Hodgkin's LymphomaDecitabine-primed Tandem CD19/CD20 CAR T Cells
Han weidong 33
Early research (Phase 1)Study completedNCT01590732
What this trial is testing

Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma

Who this might be right for
Mycosis FungoidesRecurrent Anaplastic Large Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma+8 more
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00038571
What this trial is testing

Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy

Who this might be right for
Lymphoma, B-Cell
M.D. Anderson Cancer Center 60
Early research (Phase 1)Study completedNCT02187133
What this trial is testing

Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinLymphoma
University of California, San Francisco 10
Not applicableStudy completedNCT04833504
What this trial is testing

Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell LymphomaMantle Cell LymphomaTransformed Follicular Lymphoma+1 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 39
Next Page